· Brannan SK et al. Onset of Action for Duloxetine 60 mg once Daily: ... . 6. 7 ... Hanan Al-Ghoj...

1

www.arabpsynet.com/Congress/CongJ36FirstIntConfPsyPl.pdf


3

Safe- high active first line treatment for psychotic disorderswith flexibility in dosing and cost-saving treatment

www.jepharm.ps

Risperidone

4

Helping your patients to achieve remission.

Back to work

Time with family

Laughing

Confidence

Taking walks

Help your patients to get back to Life

1. Brannan SK et al. Onset of Action for Duloxetine 60 mg once Daily: Double-Blind, Placebo-Controlled Studies. J Psych Res 2005; 39: 161-172. 2. Hirschfeld RM et al. Time Course of Depression-Symptom Improvement during Treatment with Duloxetine. Depress Anxiety 2005; 21: 170-177.

Psychiatry 2004; 65: 521-530. 4. Detke MJ et al. Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double Blind Placebo Controlled Trial. J Clin Psychiatry 2002; 63: 308-315. 5. Perahia DG et al. Duloxetine in the Prevention of Relapse of Major Depressive Disorder: Double-Blind Placebo Controlled Study. Br J Psychiatry 2006; 188: 346-353.

Trial. Am J Psychiatry 2007; 164: 900-909.7. Poster presented at ACNP; Scottsdale, Arizona, USA; December 7-11, 2008.

Cymbalta 60 mg QD offers:Rapid and Dependable efficacy on broad range of Symptoms:•

Unsurpassed efficacy on low mood and associated anxiety. − 1,2

Superior efficacy on vague body aches and cognitive function improvement. − 2,3

Consistent and higher remission rates.• 1,4,5,6

Effective prevention of depressive recurrence.• 7


Back to work

Time with family

Laughing

Confidence

Taking walks


CY

MM

DD

-DC

-2-M

EN

A-1

2/20

09

5


Back to work

Time with family

Laughing

Confidence

Taking walks


1. Brannan SK et al. Onset of Action for Duloxetine 60 mg once Daily: Double-Blind, Placebo-Controlled Studies. J Psych Res 2005; 39: 161-172. 2. Hirschfeld RM et al. Time Course of Depression-Symptom Improvement during Treatment with Duloxetine. Depress Anxiety 2005; 21: 170-177.

Psychiatry 2004; 65: 521-530. 4. Detke MJ et al. Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double Blind Placebo Controlled Trial. J Clin Psychiatry 2002; 63: 308-315. 5. Perahia DG et al. Duloxetine in the Prevention of Relapse of Major Depressive Disorder: Double-Blind Placebo Controlled Study. Br J Psychiatry 2006; 188: 346-353.

Trial. Am J Psychiatry 2007; 164: 900-909.7. Poster presented at ACNP; Scottsdale, Arizona, USA; December 7-11, 2008.

Cymbalta 60 mg QD offers:Rapid and Dependable efficacy on broad range of Symptoms:•

Unsurpassed efficacy on low mood and associated anxiety. − 1,2

Superior efficacy on vague body aches and cognitive function improvement. − 2,3

Consistent and higher remission rates.• 1,4,5,6

Effective prevention of depressive recurrence.• 7


Back to work

Time with family

Laughing

Confidence

Taking walks


CY

MM

DD

-DC

-2-M

EN

A-1

2/20

09

Disturbing & frightening

thoughts U

ncontrollable aggression

A danger to himself and

others Brought into hospital by

police

Kinon BJ et al. Am

J Emerg. M

ed. 22:181-186, 20041.

Tiihonen J et al. BMJ 2006:333:224-227

2. Kahn RS et al. Lancet 2008; 371 : 1085-1097

3. H

aro J et al. European Neuropsychopharm

acology 2007; 17:235-2444.

Kinon BJ et al. J Clin Psychopharmacol 2006; 26: 453-461

5. Tohen M

et al. Arch G

en Psychiatry 2002; 59:62-696.

Kikkert MJ et al. Schizophrenia Bulletin 2006; 32(4): 786-794

7. N

amjoshi M

A Journal of A

�ective Disorders 2004; 81: 223-229

8. Ciorabai EM

et al. Eur Psychiatry 2008; 23:S150 (P0237)9.

Taking medication but

struggling to cope

Frequent relapses and

multiple hospitalizations

Unstable fam

ily life

Zyprexa helps patients

get better faster andstay better longer.

A first-choice m

ood stabilizer in

Zyprexa helps patients

get better faster andstay better longer.

When a rapid response is critical

Rapid dependable relief in acute patients6

Relapse prevention in long term treatm

ent 7

8

Rapid dependable relief in acute patients1

Patients stay longer on Zyprexa2, 3, 4

5

Velotab... fast, easier & better com

pliance9

ZYP-PU-1-MENA-12/2009



7

Congress Information:

Registration Fees:Participation 25 USD Companion Person 12 USDFees include access to the scientific sessions, professional exhibitions, opening ceremony, congress bag, coffee breaks and meals.

Target Group:Doctors, Pharmacists, Nursing, Socialists, Psychologists, Occupational and Re-habitation Specialists and University Students.

Venue:The congress will be held at The Grand Park Hotel – Ramallah in 11th, 12th of October, 2012.Hotel Accommodation:The Grand Park Hotel – Ramallah.

Official Language:English

Inquiries regarding registration, hotel reservation, scientific program, exhibition and other matters related to the congress, please contact:Dr. Ziyad ArandiAssistant Professor of PsychiatryPresedent of Palestinian Psychiatric AssociationMobile: +970 59 9785530

9

Chairman of congressDr ziad arandi

Co-chairmanDr bassam ashhab

Congress scientific adviser Dr walid sarhan

Chairman of scientific committeeDr bassam ashhab

Executive committeeDr Mustafa MujahedDr ziad arandi dr ivona AmlehDr hazem ashourDr issam BannouraDr bassam ashhabDr ibrahim ikhmayyesDr iyad Al-azzehDr mahmoud khraishi

Scientific committeeDr ziad arandi Dr bassam ashhabDr hazim ashoorDr isam BanoraDr mahmood ishrishiDr ivona imlih

International advisory committeeProf ahmad okasha- egyptDr walid sarhan –jordanProf tareq okasha- EgyptProf mohammad abou saleh- QatarProf alean al-krenani -newfoundlandDr abdallah abdelrahman- sodanProf Abdul Monaf Al-Jabiry- IraqDr abdallah abdelrahman- sodanDr Osama tawakol Othman - ukDr adnan takriti -JordanDr elie karam –LebanonProf fawzi taemeh JordanDr iyad khries -usaDr Sameer Samawe

12

World Psychiatric Association Medical Association Palestinian Psychiatric Associa-tion

The First International Psychiatric

Conference in Palestine

The Palestinian Psychiatric Association with the Cooperation of theWorld Psychiatric Association

11th, 12th October 2012

Grand Park Hotel – Ramallah – Palestine

www.ppsya.ps

13

The Scientific Program

Thursday, 11th October 2012

Registration 9:00 – 9:30

Opening Ceremony 9:30 – 10:00

Moderator: Dr. Issam Banoura

Palestinian Minister of Health

Chairman of General Medical Association

President of the Palestinian Psychiatric Association

Memorial Lecture

Dr. Bassam Ashhab Mental Health

Services in WestBank

10:00 – 10:20

Coffee Break 10:20 – 10:50

Mental Health ServicesDr. Issam Banoura Dr. Malek Hassan

Title Doctor Country Time

Community Mental Health in the US Dr. Elizabeth Berger USA 10:50 – 11:05stigma and disciminationtoward mental illness Dr. maria alonso spain 11:05 – 11:20

Salfit Community Mental Health Center Mr. Jamil Nassif Palestine 11:20 – 11:35

Primary Care Mental Health Dr. John Gleisner UK 11:35 – 11:50

thirteen years medicare experiance in tdm Dr. bashar al-karmi Palestine 11:50 – 12:05

Discussion - 12:05 – 12:30

14

Clinical psychopathologyDr. Iyad Al-Azzah Dr. Fayez Yamen


Guidelines for Diagnosis & Treatment Assistant prf. Ziyad Arandi Palestine 12:30 – 12:45

Violence Among Palestinian Unv Students Prof. Muham Haj-Yahia Palestine 12:45 – 1:00

depression Dr. Hazem Ashour Palestine 1:00 – 1:15

.Risks and Benefits Antipsychotic Com Prof. Waleed Sweileh Palestine 1:15 – 1:30

Discussion – 1:30 – 2:00

Launch Break 2:00 – 4:00

Academi psychiatryDr. Ziyad Arandi Dr. Nidal hamad


.Gene Discovery for Schizoph Dr. Hashem Shahin Palestine 4:00 – 4:15

.Dyslipidemia Among Schizoph Dr. Iyad Ali & Dr.Sami Abwini

Palestine 4:15 – 4:30

Addiction Ms. Thawra Anjas Palestine 4:30 – 4:45

Pregnancy and Drugs Dr. Samah Jaber Palestine 4:45 – 5:00


Dr. Mahmud Ikhrishi Dr. Saheb Al-Saheb

Quitapine Atyp Anti Psy Drug Dr. dr sameer samaw-JD 5:30 – 6:00

Islamic Psychiatry Dr.mustafa mujahed-PS 6:00 – 6:30

Social Entertainment + Dinner 7:00 – 10:00

15

The Scientific Program

Friday, 12th October 2012

Child Mental HealthDr. Basam ashhab Dr. khader rawagbe


Emergency Types of Behavioral Disorders Prof. Anwar Duden Palestine 8:30 – 8:45

ADHD Dr. ayda al-qutsi Sweden 8:45 – 9:00

Care to Autistic Spectrum Disorder Children Dr. Souha Shehadeh Palestine 9:00 – 9:15

The Use Of Griffith Men. Dev. Scales Dr. Walid Ka’adan Palestine 9:15 – 9:30

Multi-factorial measures of parenting Prof. Marwan Dwairy Palestine 9:30 – 9:45


Coffee Break 10:00 – 10:20

Dr . Riyad Zawahreh Dr. Nour Eden Qaqa


Social psychiatri Dr. David Baker Germany 10:20 – 10:35

Attitude Of Professionals Towards Ment Patients Dr. Muna Ahmad Palestine 10:35 – 10:50

THE PSYCHOLOGICAL PROP AND HELP SEEK BEHAV Dr.dr adnan sarhan Palestine 10:50 – 11:05

Discussion 11:05 – 11:25

Praying 11:25 – 1:00

16

Dr .Adam Afaneh Dr Ivona Al-amlihTitle Doctor Country Time

Improving Access To M.H.S (Area C) Jericho Dr.Maher Said - Maria Alonso PALES - SPAIN 1:00 – 1:15

Coming Up With Research Ideas In Pales Dr. WAEL MUSTAFA PALESTINE 1:15 – 1:30

Coping With Trauma In Palestinan Children Dr.ABDEL-AZIZ THABET PALESTINE 1:45 – 2:00

Launch Break 2:00 – 3:00

Dr. Asad Abu Galion Ibrahim Ikhmayes

Play - Drama As Abehavior Treatment Dr.MOHAMAD AL-KHATEB PALESTINE 3:15 – 3:30

variation of men. health for unve student dr kamel ketelo PALESTINE 3:30 – 3:45

job burn Ms. Nehayeh Jaber PALESTINE 3:45 4:00

Certificates & Final Recommendations Session 4:00 – 5:00

Dr . Bsam Ashhab Dr. Ziad Arandi Dr. Hazem Ashor Dr. Mahmud Ikhrishi Dr. Issam Banoura

18

Acknowledgements

platinium sponser Astrazeneca

Jerusalem pharmacuticals co.ltd

Golden sponser

medicacal supplies and services

Silver sponser

Beit jala pharmaceutical co. alrazi drug store company

Novartis company

Pharmacare plc

20

Improving access to Mental Health Services at Jericho District (Area C) through Coordination, Support and Awareness Program at Primary Health Clinics. Dr. Maher Said, Heba Balo, Hanan Al-Ghoj and Maria Alonso

About 22.5% of the total Jericho district population`s live in Area C (rural areas). Mentally ill person`s which reside in these area are at a greater disadvantage due to limited access to health care, a scarcity of resources, distance, Israeli check points, lower incomes and traditional cultural belief systems.Specific strategies are needed to provide the support health system for managing and coping with mental health problems.In this presentation we will share the first 5 months experience of the “Mental Health And Area C Primary Health Care At Jericho District Coordination, Support And Awareness Program”: goals, activities, results, difficulties and lessons learned. This Program aims to increase access to mental health services by the integration of mental health services into the primary health care thought scheduled activities run by MH team in the clinics located in Al Oja, Al Jiflik, Zbeidat and Al Fasayel. The beneficiaries of these activities are the PHC staff (training, coordination, and supervision), the general population attending PHC clinics (awareness) and mental health patients living in this area (assessment, follow-up, supervision of PHC intervention). This is new experience for the CMHC of Jericho but a promising methodology to improve access and decrease stigma to mental health issues.

21

Stigma and discrimination toward mental illness: translation and validation of the Arabic version of the attribution questionnaire-27 (AQ-27-I)Dr. Maher Said, Maria Alonso Suarez, Ana I. Guillen Andres, Manuel Muñoz Lopez, Alberto Fernández Liria, Hanan Al-Ghoj and Heba Balo

This study has 2 aims: 1) Analyze the stigma associated with severe and persistent mental illness in the general population of the District of Jericho, Palestine, as a first step to promote strategies to fight against it; and 2) Translate the Attribution Questionnaire-27 (AQ-27) to the Arabic language (AQ-27-I), and to examine the reliability and validity of the Arabic version. Results about stigmatizing attitudes are presented, along with statistical results about reliability, internal consistency and factor analysis that determine the reliability of the Arabic version of this instrument.

22

Iyad Ali* and Sami Abwini

*Faculty of medicine and health sciences,

An-Najah National University,

Title: prevalence of dyslipidemia among schizophrenic clients attending governmental psychiatric clinics in northern Palestine.

Background

Individuals with major mental health disorder lose about twenty years of life expectancy due to coronary heart disease (CHD), the leading cause of death. Dyslipidenia is a common health problem worldwide and its prevalence is raising steadily. Schizophrenic clients are particularly at higher risk of having dyslipidemia and at higher risk of dying from cardiovascular diseases.

AIM: The aim of the study is to determine the prevalence of dyslipidemia among schizophrenic clients who are attending governmental psychiatric clinics in northern Palestine.

23

An evaluation of the effectiveness of Primary Care and Mental Health Integration.

Each Community Mental Health Care Center (CMHC) receives a small proportion of its patients as referrals from Primary Care Physicians (PCP).Over the past 2 years the Ministry of |Health with support from the WHO has held training courses for PCPs in mental health for the purpose of providing better care for patients attending primary care. As part of that training doctor were taught to diagnose illness and where they needed further help in management and treatment to refer those patients on to the CMH›s.This research concentrates on the referral process. The results of an analysis can be used as a proxy for PCP practice. There is a substantial literature on referrals from primary to secondary care and the correspondence to and from specialists. This will be very briefly reviewed.During the month of May 2012 all referrals from PCPs were identified and the letters/forms be photocopied and collected. To preserve anonymity, patient and PCP identifying data were erased. With each letter a short form was completed by the CMHC psychiatrist, rating the helpfulness of letter›s information and the accuracy of the information.The background statistics will be presented which in themselves are interesting and worthy of consideration and the results of the May survey presented. It is hoped that is will give pause for consideration as to the best realistic way to provide useful information to CMHC psychiatrists.It is suggested that this procedure can be repeated annually and the results used as one measure of the changes and improvements in the integration of PC and mental health services.John Gleisner. May 2012.

24

Assessing Risks and Benefits of Antipsychotic Combination in Palestine with Schizophrenia

Waleed M. Sweileh College of Medicine and Allied Health SciencesAl-Najah National University

Abstract

Background: Antipsychotic drug combination, the practice of using more than one antipsychotic drug to manage psychotic disorders is a common practice. However, evidence supporting this practice is lacking.

Objectives: To assess clinical and economic benefits and risks of antipsychotic combination versus mono-therapy in schizophrenia treatment.

Methods: A cross sectional study at the governmental psychiatric health centers in north West-Bank was carried out using patients› medical files and PANSS to assess severity antipsychotic drug was calculated based on reported values in literature. SPSS was used for analysis of data.

Discussion and Conclusion: The data indicate that there is no added value of antipsychotic combination versus mono-therapy. Actually, an economic loss is associated antipsychotic combination. Schizophrenia treatment guidelines which promote antipsychotic mono-therapy should be followed.

25

Community Mental Health in the United States-Lesson from our History

Elizabeth C. Berger MD, MPhilMichael D. Morse MD, MPA

Abstract: this paper reports on the historical development of community mental health in the United States since the 1960»s, with a review of its patient population and characteristics system problems, especially the «revolving door» phenomenon and the challenge of fragmented care. The authors describe participation in subsequent reforms and provide recommendations based on that experience. Recommendations cover principles of clinical and administrative practice, as well as placing community mental health within a public health context. Principles of clinical practice include respect for patient rights, the formation of multidisciplinary treatment teams, and the process of comprehensive psychiatric evaluation. Principles of administrative practice include clear documentation of policy and procedure-especially regarding the management of crises and the boundaries of treatment-effective QA process, and staff development. It will be important to place mental health into an overall agenda for public health with an emphasis on coordination of diagnosis and treatment for mental disorder and general medical condition. In accordance with WHO and UN recommendations, achieving public health goals, including goals form mental health, will be as dependent upon reducing global risk factors such as poverty and violence; prevention in mental health must be linked with advocacy for social justice.

26

Abstract

Iyad Ali* and Sami Abwini

*Faculty of medicine and health sciences,

An-Najah National University,

Title: prevalence of dyslipidemia among schizophrenic clients attending governmental psychiatric clinics in northern Palestine.

Background

Individuals with major mental health disorder lose about twenty years of life expectancy due to coronary heart disease (CHD), the leading cause of death. Dyslipidenia is a common health problem worldwide and its prevalence is raising steadily. Schizophrenic clients are particularly at higher risk of having dyslipidemia and at higher risk of dying from cardiovascular diseases.

AIM: The aim of the study is to determine the prevalence of dyslipidemia among schizophrenic clients who are attending governmental psychiatric clinics in northern Palestine.

27

Cumulative Exposure to Family Violence and Development of Post-Treatment Stress among Palestinian University Students AbstractSubmitted by:Muhammad M. Haj-Yahia,Ph.d.

Extensive research has been conducted in recent decades on the mental health consequences of children›s exposure to family violence. The available research has focused either on the impact of witnessing interparental violence (especially father-to-mother violence) or on experiencing parental abuse and violence. However, available research has rarely examined the effects of exposure to the co-occurrence of both patterns of family violence (i.e., witnessing violence and experiencing violence). In addition, existing research has been conducted mostly among samples known to health and mental service, i.e., among clinical samples of children who have been exposed to serve patterns of family violence. However, research has rarely been conducted among community samples, which could include participants who have been exposed to wide range of frequencies and severities of family violence. Furthermore, there is a serious dearth of research on cumulative exposure to family violence, where most available research has examined the effects of this exposure during childhood and/or adolescence, with special focus in the recent year of the occurrence of family violence. Hence, available research ignored the possible effects of this exposure during early adulthood and effects of cumulative exposure during childhood, adolescence and young adulthood.

28

Dr Marwan Dwairy

Studies on parenting typically focus on one or two parental factors such as authoritarian, authoritative and permissive parenting of acceptance-rejection factor. Based on the understanding that parenting is a complex process and on that parenting factors may overlapping (such as authoritarian and rejection), the author (Dwairy) has suggested a multi-factorial method of research and has developed a scale that measures seven different factors: Punishing in the name of love, addressing the child›s conscience, unconditional acceptance and authoritarian parenting. The questionnaire in addition to another questionnaire that measure psychological disorders among children was administrated to 900 teenagers (15-17 years old) in three cultures: Palestine, British and Algerian. The results shows that the scales were valid and reliable and revealed four different patterns (profiles) of parenting each consists from seven factors. Each pattern was associated with different level of psychological disorders. Interesting cross-cultural and gender differences in parenting patterns were found. To our knowledge, this is the first study of parenting that is based on a multi-factorial scale of parenting. Based on further research the Dwairy Multi-factorial Parenting Scale (DMFPS) may contribute a lot to parenting research and to clinical work with families.

29

Dr. Abdel Aziz Thabis Ph.d

Abstract

Aim: The aim of the study was to investigate the effect of trauma after one year of Gaza War on children PTSD, anxiety, fears and depression and coping as mediator factor.

Methods: The study sample consisted of 449 children from who were exposed to the Israeli war on the Gaza stripe. Children completed measures of experience of traumatic events (Gaza Traumatic Events Checklist-20 items, War on Gaza), PTSD, Birleson Depression Scale, Child Revised Manifest Anxiety Scale and Fear scale.

ConclusionThis study showed that after one year of Gaza war still Palestinian children had the impact of traumatic experiences on their mental health. Children are suffering of depression, anxiety, PTSD and fears. All those reactions were related to traumatic events. However, children are able to cope with such reaction by using different ways of coping, mainly try to feel better by spending time with others like family, grown-up of friends, try to sort out the problem, and try to sort out the problem by doing something or talking to someone about it.

Key works: One year of Gaza War, Children, PTSD, Depression, Anxiety, Fears, Coping.

30

Gene discovery for schizophrenia by exome sequences of multiple-affected consanguineous Palestinian families.Hashem.Shahin

Such mutations as recessive alleles. We have ascertained 5 families severely affected with schizophrenia from the Bethlehem Mental Hospital, the only mental hospital in Palestine. Medical chart reviews, and when possible interviews, were conducted for all family members who were patients of the hospital. Further psychiatric history was obtained during home visits by a psychiatrist. All affected individuals meet DSM-IV criteria for schizophrenia or schizophaffective disorder. As an initial screening process, we genotyped all affected individuals for the nine large recurrent schizophrenia-associated hospital CNVs and determined that none were homozygous or heterozygous carriers. We then performed exome sequencing on 18 affected individuals to high median depth of coverage (125x). We generated private and rare SNP and indel variants for each individual by filtering against common variants in publically available databases and 24 exomes that we have sequenced from Palestinian and other Middle Eastern individuals with no history of mental health disorders. Variants that were predicted to truncate proteins or lead to damaging mutations were Sanger sequence validated and genotyped in additional family members to exclude variants that did not segregate with schizophrenia within the families. For consanguineous families we prioritized further evaluation of variants that were predicted to be within large blocks of homozygosity. We have uncovered a number of compelling candidate mutation some in genes which have previously been implicated in idiopathic mental retardation.

31

Guidelines for Diagnoses and Drug Treatment of Some Psychiatric Disorders Dr. Ziad Arandi

Assistant Professor of Psychiatry

Faculty of Medicine An-Najah National University

The presentation explains the outlines for diagnoses and drug treatment for some acute psychiatric disorders; it includes how the diagnoses can be summarized by a number of symptomizes and signs and the duration to reach the diagnosis.

The other parts include how the drug treatment should be ordered.

This summarization can be put in one page in front of the psychiatrists which can help them to run quickly to the outlines of diagnosis and the duration of the drug.

32

Islamic psychologyThe physiology of human sciences

قبل ان يدرس االنسان العلوم الطبية يدرس علم وظائف االعضاء او وظائف هذه العلوم ثم يدرس ماذا يحدثاذا اضطربت هذه الوظائف علم االمراض وكالهما من العلوم االساسية وبعدها يبدا

33

PA›s Ministry of Health

Jameel Nasser

Inherited from the Israeli military administration health services that had been neglected and starved for funds during the years of Israeli occupation (Giacaman et al. 2009).Palestinian Ministry of Health was started to make attempts to expand services beyond the hospital, most services continue to be hospital-based, fragmented and rooted in biomedically oriented approach (WHO, West Bank and Gaza Office 2006).

34

Providing care to children with Autism Spectrum Disorders in Palestine: the psychiatrist›s role in the community

Dr Souha MANSOUR SHEHADEH

In the last decades, childhood professionals started showing more in autistic spectrum disorders in Palestine and are actually feeling that there is an increase of the number of patients with autism, but until now we have no define epidemiological study on the question. Parents are more and more consulting psychiatrists and asking them for help, not only to confirm the diagnosis but also expecting a treatment plan. What is the role of the psychiatrist in providing care to autistic children and how to propose an integrated approach in the country where autism has recently become at the heart of many debates? What to do in the current situation while waiting for the application of a national policy on autism spectrum disorder? In order to analyze the difficulties we are facing in Palestine, I will draw upon two examples of patients followed up in child psychiatry in Bethlehem. I will insist on the counter transference processes that are marked by feeling of helplessness because of the lack of training and the absence of positive perspectives for the future of the country. However, despite the lack of resources, the conjunction of psychodynamic support of children and their families, of medical care when needed, of speech and occupational therapy and of their integration in education setting-even if not specialized-can lead to interesting results.

35

The attitudes of mental health professionals towards patients with mental illness in an inpatient setting in Palestine

Dr. Muna Ahmad

Cultural play a vital role in shaping public and professional attitudes towards mental illness. In Arab cultures negative attitudes toward patients experiencing mental illness are common. There is a lack of studies that investigate the attitudes of professionals towards patients in inpatient mental health setting.

This study aimed to assess the attitudes of professionals towards patients with mental illness in the only psychiatric hospital in Palestine. A survey was undertaken using the Attitudes toward Acute Mental Health Scale (ATAMHS 33). The scale was distributed to a variety of professionals at the only psychiatric hospital in Bethlehem. Data was managed and analyzed by using SPSS 15 (a statistical package for social sciences).

The participants expressed both negative and positive attitudes toward patients, however, results revealed more negative than positive attitudes, particularly in relation to alcohol misuse, medication, patients› ability to control their emotions and genetic predisposition to mental illness. This paper provides baseline data about the attitude of mental health professionals towards patients experiencing mental illnesses. Education and direct contact with patients with mental illness may not be enough to foster positive attitudes towards them.

This may indicate the need to revise educational curriculum at Palestinian universities and offer more training for mental health professionals in order to change their attitudes

Key Words: acute mental health setting, attitudes, inpatient, mental health professional, patients.

36

Thirteen years Medicare experience in TDM

In 1999 Medicare presented its first experience and notes in Therapeutic Drug Monitoring «TDM».In that study, approximately 100 samples were tested in Medicare between the periods 19961999-. The study showed that 30% of the tested subjects were» under treated» while 20% were «over dosed». Only the half of patients received the treatment in the «recommended dosage».Six years latter- in 2006, the same study was performed using the same criteria and the same methodologies. During the 2006 yeas study, more than 529 samples were tested. This second study showed that more than one third (37%) of the tested subjects were under treated, 9% were over dosed while slightly more than one half were receiving the proper dosage.Our current 2012 year study will include more than 2600 samples. In this context we are trying to analyze the progress of our medical practice using «TDM» medication and the trends dealing with this group of mainly «antiepileptic» drugs.We believe that close clinical monitoring and TDM are highly needed in these cases for both, medico-legal as well as for health economic purposes.

Speaker: Dr. Bashar Al Karmi

37

Wael Mustafa Abuhasan, PhD.,Arab American University of Jenin,

Synopsis: Reviewing the medical literature whether in Palestine on in the Middle East and North Africa region indicates a clear dearth interest in research in the world of psychiatry. The critical thing here, is to find a significant research question that one can deal with easily, ethically, and find a resource where results could be disseminated. It seems that many clinicians have some difficulties at initiating a research work, possible do not know how and from where to start, or possible believing that research is a task that is beyond capacities and aptitudes! In this paper, we are going to shed the light on those minimum needed skills and requirements for helping the Palestinian psychiatrist in starting a research work that could be fascinating, feasible and researchable. The most important cues and keys for such a work will be highlighted and we addressed.

38



· Brannan SK et al. Onset of Action for Duloxetine 60 mg once Daily: ... . 6. 7 ... Hanan Al-Ghoj...

Documents

Transcript of · Brannan SK et al. Onset of Action for Duloxetine 60 mg once Daily: ... . 6. 7 ... Hanan Al-Ghoj...